Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
221 studies found for:    Open Studies | "Fatty Acids, Omega-3"
Show Display Options
Rank Status Study
21 Recruiting Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
Condition: Breast Cancer
Interventions: Dietary Supplement: Omega-3 Fatty Acids;   Other: Placebo Capsule;   Other: Diet and Exercise
22 Unknown  Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children
Conditions: Lifestyle-related Condition;   Overweight and Obesity;   Essential Fatty Acid Deficiency
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Placebo
23 Recruiting OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer
Condition: Pediatric Cancer
Intervention: Dietary Supplement: Omega-3 enriched fruit juice
24 Recruiting Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
Condition: Inflammatory Responses
Interventions: Drug: 4 g prescription omega-3 concentrate;   Drug: Placebo
25 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
26 Recruiting Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents
Conditions: Obesity;   Insulin Resistance
Interventions: Dietary Supplement: Omega3 and an hypocaloric diet.;   Dietary Supplement: Sunflower oil with an hypocaloric diet.
27 Not yet recruiting Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Cognition
Interventions: Drug: Alpha lipoic acid and omega-3 fatty acids;   Drug: Placebo
28 Recruiting The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Dietary Supplement: Omega 3;   Other: Physical Training
29 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
30 Recruiting n-3 PUFA for Vascular Cognitive Aging
Conditions: Age Related Cognitive Decline;   Alzheimer's Disease;   Vascular Dementia;   Endothelial Dysfunction;   Executive Dysfunction
Interventions: Drug: Omega 3 PUFA;   Drug: Placebo
31 Recruiting A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Condition: Hypertriglyceridemia
Interventions: Drug: Drug Omega 3;   Drug: Drug Omega-3 Comparator
32 Recruiting Omega-3 Dietary Supplements in Schizophrenia
Conditions: Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder;   Bipolar I
Interventions: Drug: Risperidone;   Drug: Omega-3 capsules;   Drug: Amber 50/50 Soybean/Corn Placebo
33 Unknown  Effect of Omega-3 Fatty Acid on Vitamin D Activation
Conditions: Hemodialysis Patients;   Vitamin D Insufficiency;   Vitamin D Deficiency
Interventions: Drug: Omega-3 fatty acid ethylester 90;   Other: Olive oil;   Other: cholecalciferol
34 Not yet recruiting Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
Condition: Whole Body Energy Metabolism
Interventions: Dietary Supplement: Omega-3 Complete;   Dietary Supplement: Placebo Pill
35 Unknown  The Effect of Omega-3 Fatty Acid Supplementation on Skeletal Muscle Membrane Composition and Cellular Metabolism
Condition: Skeletal Muscle Energy Metabolism
Interventions: Dietary Supplement: Omega-3 Complete;   Dietary Supplement: Placebo Pill
36 Recruiting Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function
Condition: Morbid Obesity
Interventions: Drug: Omega-3 fatty acid capsules;   Behavioral: Low calorie diet
37 Recruiting Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Dietary Supplement: Omega-3 Fatty Acids;   Dietary Supplement: Medium Chain Triglycerides
38 Recruiting DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial
Condition: Improve Healthy Ageing in Seniors; Prevent Disease at Older Age
Interventions: Drug: Vitamin D3;   Drug: Omega 3 fatty acids;   Procedure: Strength Home Exercise;   Procedure: Flexibility Home Exercise
39 Not yet recruiting Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
Conditions: Attention Deficit Disorder With Hyperactivity;   ADHD Inattention or Mixed Type;   Epilepsy;   Child
Interventions: Drug: Vayarin®, supplementation of n-3 PUFA;   Drug: PLACEBO
40 Unknown  Feasibility of Omega-3 Supplementation for Children With Language Impairments
Condition: Language Impairment
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years